当前位置: X-MOL 学术Clin. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus–Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy
Clinical Infectious Diseases ( IF 8.2 ) Pub Date : 2018-03-26 , DOI: 10.1093/cid/ciy242
Constance A Benson 1 , Janet W Andersen 2 , Bernard J C Macatangay 3 , Robbie B Mailliard 3 , Charles R Rinaldo 3 , Sarah Read 4 , Dawn R Bozzolo 5 , Lynette Purdue 6 , Cheryl Jennings 7 , Michael C Keefer 8 , Marshall Glesby 9 , Pablo Tebas 10 , Amy Falk Russell 11 , Jason Martin 12 , Paula Annunziato 11 , Zoran Popmihajlov 11 , Jeffrey L Lennox 13
Affiliation  

Herpes zoster (HZ) risk is increased in human immunodeficiency virus (HIV)–infected persons. Live attenuated zoster vaccine (ZV) reduces HZ incidence and severity in adults; safety and immunogenicity data in HIV-infected adults are limited.

中文翻译:


带状疱疹疫苗在 CD4+ 细胞计数 >200 个细胞/mL 的人类免疫缺陷病毒感染成人体内的安全性和免疫原性,经抗逆转录病毒治疗后病毒学受到抑制



人类免疫缺陷病毒 (HIV) 感染者患带状疱疹 (HZ) 的风险增加。带状疱疹减毒活疫苗(ZV)可降低成人带状疱疹的发病率和严重程度; HIV 感染成人的安全性和免疫原性数据有限。
更新日期:2018-03-26
down
wechat
bug